Unravelling underrepresented immune cell complexity in MS

Dr Belinda Kaskow

CMMIT Murdoch University, Perron Institute, The University of Western Australia, WA

January 2024

specialisation: Immunology

focus area: Causes and Prevention

funding type: Incubator

project type: Investigator Led Research

Summary

The immune system is finely balanced to allow for strong immune responses against foreign antigens (e.g. viruses) but controlled so that self-antigens do not trigger an immune response. In MS, the immune system is dysregulated, leading to immune attacks on self-antigens in the brain and spinal cord. Killer immunoglobulin-like receptors (KIRs) are found on certain immune cells and help control immune responses. However, the KIR family is highly complex and variable among individuals making it challenging to study using traditional methods.

This project will investigate KIR expression from multiple levels, including which genes are present in an individual, when those genes are expressed and what cell types express them. It will compare this between people living with MS and people living without MS to understand the differences in the KIR repertoire in MS.

To date, the available technology has limited the study of KIRs, but recent advances in the understanding of the complexity of KIR and the development of innovative approaches will allow Dr Kaskow and her team to comprehensively characterise KIR expression and elucidate of the role of KIR in MS. Understanding how KIR impacts the balance of the immune system in MS will lead to better, more targeted immunotherapies for MS in the future.

lead investigator

co-investigator

Professor Allan Kermode
Associate Professor Silvana Gaudieri
Associate Professor Abha Chopra
Dr Pooja Desphande
Mr Eric Alves
Ms Milan Pietracatella

total funding

$25,000

start year

2024

duration

1 year

STATUS

Current project

Stages of the research process

Fundamental laboratory Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline

10+ years

Translational Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline

5+ years

Clinical Studies and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline

3+ years

Read More

Newsletter subscription

  • Enter your details

Unravelling underrepresented immune cell complexity in MS